Kenvue Inc. Common Stock (KVUE)
Stock · NYSE · Consumer Discretionary
$19.17as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$17.23
Industry
Specialty Chemicals
Fundamentals
- Market cap
- $36.50B
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How Kenvue Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Feb 20, 2026 · via SEC EDGAR / Finnhub
Kenvue Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- KVUEKenvue Inc. Common Stock$19.17▼ 0.16%Market cap $36.50BP/E —
- CSLCarlisle Companies Incorporated Common Stock$356.4▼ 1.20%Market cap $14.77BP/E 20.50$293.43$432.91
- CLXClorox Company (The) Common Stock$102.58▼ 1.02%Market cap $11.88BP/E 21.81$84.7$128.9
- YHGJYunhong Green CTI Ltd. Common Stock$2.92▲ 0.00%Market cap $8.15MP/E —$2.38$10.29
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| KVUE Kenvue Inc. Common Stock | $36.50B | — | $19.17 | ▼ 0.16% | |
| CSL Carlisle Companies Incorporated Common Stock | $14.77B | 20.50 | $356.4 | ▼ 1.20% | $293.43$432.91 |
| CLX Clorox Company (The) Common Stock | $11.88B | 21.81 | $102.58 | ▼ 1.02% | $84.7$128.9 |
| YHGJ Yunhong Green CTI Ltd. Common Stock | $8.15M | — | $2.92 | ▲ 0.00% | $2.38$10.29 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Kenvue (KVUE) Stock Looks Cheap On Cash Flow But Fair On EarningsYahoo · 8/21/2026
- Should Zyrtec’s New Drug-Free Allergen Shield Spray Launch Require Action From Kenvue (KVUE) Investors?Yahoo · 8/21/2026
- Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its FutureYahoo · 8/20/2026
- Will a Neutrogena boycott by Hayden Panettiere's fans work?Yahoo · 8/20/2026
- Kenvue (KVUE) Launches Zyrtec Spray As Its Undervalued Case Faces A Fresh TestYahoo · 8/20/2026
- Essity acquires feminine care business in BrazilYahoo · 8/20/2026
- Essity Strikes Agreement To Acquire Kenvue's Feminine Care Operations In Brazil For $284MBenzinga · 8/19/2026
- South Africa's Competition Tribunal Says Deal Between Kimberly-Clark Corporation And Kenvue Approved With ConditionsBenzinga · 8/14/2026
Insider Activity
Insider Actions →Acquired
138.4K
Disposed
3.7K
- Anindya Dasgupta · July 31, 2026 · Option Exercise16.4K
- ALLISON RICHARD E JR · June 29, 2026 · Grant1.4K
- Smith Jeffrey C · June 29, 2026 · Grant1.4K
- Heather Howlett · June 10, 2026 · Sale3.7K @ $18.11
- Mann Erica L · May 21, 2026 · Grant10.3K @ $17.46
- Seemantini Godbole · May 21, 2026 · Grant10.3K @ $17.46
- Hofstetter Sarah · May 21, 2026 · Grant10.3K @ $17.46
- Sneed Michael E · May 21, 2026 · Grant10.3K @ $17.46
- PAWLUS KATHLEEN M · May 21, 2026 · Grant10.3K @ $17.46
- ALLISON RICHARD E JR · May 21, 2026 · Grant10.3K @ $17.46
- Healey Melanie · May 21, 2026 · Grant10.3K @ $17.46
- Smith Jeffrey C · May 21, 2026 · Grant10.3K @ $17.46
- Vasant M. Prabhu · May 21, 2026 · Grant10.3K @ $17.46
- MERLO LARRY J · May 21, 2026 · Grant16.0K @ $17.46
- Betsy D. Holden · May 21, 2026 · Grant10.3K @ $17.46
Institutional Ownership
March 31, 2026
- Total shares held
- 1.65B
- Total value held
- $27.16B
- Institutional holders
- 994
Top holders this quarter
- Unknown145.30M
- Unknown135.09M
- Unknown124.42M
- Unknown119.57M
- Unknown56.60M
- Unknown51.27M
- Unknown49.74M
- Unknown49.21M
- Unknown32.40M
- Unknown27.31M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedSynthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
August 30, 2026
Kenvue in focus as Kimberly-Clark takeover talks face uncertainty. Kenvue has been in the news recently over a possible acquisition by Kimberly-Clark. One article describes the deal as looking imminent, while a later report says the acquisition has hit an obstacle, leaving the outcome unclear. Kenvue also appears on recent lists of top dividend-paying stocks, supported by a 4.47% dividend yield. The mixed signals around the deal, combined with the stock trading near the lower end of its 52-week range, have drawn attention from income-focused and event-driven investors.